Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

NCT01087502 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Glimepiride
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Linagliptin

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]